Genetic counselors have advanced training in both medical genetics and counseling to best provide personalized help to patients with genetic test results and all that it implies, such as how inherited diseases may affect them or their families, the chance of disease occurrence (or recurrence), and how to make the most informed decisions. Most work in a medical setting and some work in research, and they may specialize in an area such as cancer genetics. The LFS Association’s Genetic Counseling Advisory Group (GCAG) members work in medical settings and collaborate on research. Together, we are working on addressing the needs of our LFS community.
LFS Association’s Directory of Genetic Counselors
Here’s a brief list of international genetic counselors who we know are knowledgeable on Li-Fraumeni syndrome that you may reach out to for guidance. Along with the names, facilities, and contact information, are the services available at their facilities and the age groups they serve (children/adults).
The National Society of Genetic Counselors offers a “Find a Genetic Counselor” feature on their website, with options to meet by phone or person. They also support a patient resource website that may be able to answer many of your concerns regarding genetic counseling. See “About Genetic Counselors” for more information.
Articles of interest relevant to genetic counseling and Li-Fraumeni syndrome:
In June 2017, as part of their Pediatric Oncology Series, the American Association of Cancer Research published, “Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient.”
In November 2015, researchers published, “Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome” in the Journal of Genetic Counseling
Additional resources developed by the LFS Association’s Genetic Counseling Advisory Group for you!
Download this invaluable tip sheet, “Insurance Info Sheet 2022,” to help guide you through some basic insurance options. (2022)
Here’s a list of Frequently Asked Questions, and their answers. (2021)
Printable Quick Reference Resource for Mental Health Providers delineating challenges that families with LFS face. (2021)
Our first LFS Awareness Brochure for Teens, designed especially for our teens and young adults! (2021)
“LFS and Living My Best!” Designed for children aged 8 – 13, download and review the booklet, “LFS and Living My Best!” and decide if it’s the right time to share with your child.
Members of the LFS Association Genetic Counseling Advisory Group include:
Katherine A. Schneider, M.P.H., L.G.C. – Co-Chair
Katherine Schneider graduated from Yale University with a Masters Degree in Public Health. She is a licensed genetic counselor in Massachusetts. She has 25 years experience in cancer genetic counseling. Ms. Schneider is a Senior Genetic Counselor at the Dana-Farber Cancer Institute. She works in the Center for Cancer Genetics and Prevention and the Pediatric Cancer Genetic Risk Program, and helps oversee the Dana-Farber Cancer Genetics Satellite and Affiliate Program. She is also a member of the Dana-Farber Ethics Committee. Ms. Schneider previously served as President of the National Society of Genetic Counselors and wrote the textbook: “Counseling about Cancer: Strategies for Genetic Counseling”, which is currently in its 3rd edition.
Jenn Perry – Co-Chair
Jenn Perry is married to her best friend and love of her life, Bert, with two wonderful daughters. Jenn currently works with Dunkin’ Donuts Brand serving as an Operations Manager. Jenn enjoys many activities, but her passion is competitive show jumping in the equestrian world. In fact, she has designed and executed two different annual walks for cancer, one of them, Hoofin’ For The Cure, involved her horse Maximus. Jenn is a breast cancer survivor who was diagnosed with Li-Fraumeni syndrome just a few years back. Jenn is committed to advocating for all those who battle cancer, whether they are a patient or a researcher, in creating positive and hopeful outcomes. She always knew it was a possibility that she could develop cancer, as her mother died of breast cancer after an 8 year fight. Her mother taught her to be positive and live her life to the fullest no matter what the circumstances; to see the glass half full with her mother’s inspiration at the forefront. Jenn knew she found a way to help create solutions when she attended the first Li-Fraumeni Conference in 2010. She is very honored and excited to be the President of the Li-Fraumeni Syndrome Association, Inc.. Jenn knew she finally found an avenue in which to make a difference and effect change in an area that has affected not only many members of her family, but so many families around the world. She envisions a world someday where her children, grandchildren, and future family, won’t have to live in fear of the disease we know as cancer.
Rose B McGee, M.S., C.G.C.
Rose McGeee completed her genetic counseling training at the University of Pittsburgh School of Public Health. She is a certified genetic counselor practicing at St. Jude Children’s Research Hospital in the Division of Cancer Predisposition. She sees families in a busy clinic, evaluating for cancer predisposition syndromes including Li-Fraumeni syndrome. As well, she is involved in research endeavors that study incorporation of genomics into clinical care and psychosocial impact of cancer surveillance in families with predisposition syndromes. Rose is thrilled to interact further with families and medical providers affected by Li-Fraumeni syndrome through the LFSA.
Bita Nehoray, M.S., L.C.G.C.
Bita Nehoray is a licensed board-certified genetic counselor specializing in cancer genetics. She received her Master’s degree in Human Genetics and Genetic Counseling from Stanford University. Bita joined the City of Hope Division of Clinical Cancer Genomics in 2012, where she provides cancer genetics services for patients and families suspected to have a hereditary predisposition to cancer, with a focus in Li-Fraumeni syndrome. She is fluent in Spanish and Farsi, and is committed to advancing the provision of cancer genetics services to medically underserved and culturally diverse populations. Other clinical responsibilities include providing pro-bono cancer genetic counseling services to underserved Latino families through an outreach program established by the Division of Clinical Cancer Genomics and supported through government and foundations grants and compassionate funding. Current research projects include assessing the influence of pre-consultative interventions in the uptake of genetic counseling services in Latinas, and understanding the prevalence of somatic TP53 mutations and how they can confound genetic test results and clinical outcomes. She is an active member of the National Society of Genetic Counselors.
Kristen Shannon M.S., L.C.G.C.
Kristen Shannon received her bachelor’s degree from the College of the Holy Cross and her master’s degree in Human Genetics from Sarah Lawrence College. She has been a practicing genetic counselor at the Massachusetts General Hospital Cancer Center’s Center for Cancer Risk Assessment (CCRA) since 1997. In addition to her clinical practice, Ms. Shannon has served on various subcommittees of the National Society of Genetic Counselors. Ms. Shannon is also a member of the NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel. She was an integral part of the Massachusetts Genetic Counselors Licensure task force and served on the Massachusetts Board of Licensure for Genetic Counselors for eight years. She has lectured and published widely in the fields of cancer genetics and cancer genetic counseling.
Kristin Zelley, M.S.
Kristin Zelley is a board-certified and licensed genetic counselor who has worked in the Division of Oncology at the Children’s Hospital of Philadelphia since November 2010. As the primary genetic counselor for the Cancer Predisposition Program, she works with a multidisciplinary team that addresses the needs of children with genetic cancer predisposition. She has a strong interest and knowledge foundation in genetic predisposition to cancer in children, including conditions such as LFS. Her research interests include the psychosocial impact of cancer predisposition syndromes on children and their families, ethical issues surrounding genetic testing of children, and communication with children regarding genetic testing and results.
Wendy Kohlmann, M.S., C.G.C.
Wendy Kohlmann is a board-certified genetic counselor with a master’s degree in genetic counseling from the University of Cincinnati and a bachelor’s degree in zoology from the University of Wisconsin. She has worked as a genetic counselor at the University of Texas-M.D. Anderson Cancer Center in Houston and the University of Michigan Comprehensive Cancer Center in Ann Arbor. She began working at Huntsman Cancer Institute as a research associate in 2006. Wendy Kohlmann’s research interests include the inherited basis of melanoma and pancreatic cancer, psychosocial and behavioral outcomes of genetic counseling, and issues for children and adolescents with hereditary cancer syndromes.
Kami Wolfe Schneider, M.S., C.G.C.
Kami Wolfe Schneider is a Senior Instructor working full time for Children’s Hospital Colorado in the Hematology, Oncology, and Bone Marrow Transplant Division since June 2013 at the University of Colorado. A 2005 graduate of the University of Cincinnati’s genetic counseling program and ABGC board certified since 2007, she worked as a cancer and prenatal genetic counselor in Memphis, TN for more than 4 years, at which time she provided genetic counseling to mostly adults, but also some children referred from St. Jude Children’s Research Hospital, with or at-risk for Li-Fraumeni syndrome. She then joined Children’s Hospital Colorado’s Clinical Genetics and Metabolism department in December 2009. She initiated and developed the hospital’s first pediatric cancer genetic counseling clinic which began in March 2011, and she has since expanded the genetic counseling services in the Division of Hem/Onc/BMT to include 2 full time genetic counselors covering specialty clinics including Solid and liquid tumor, Neuro-Oncology, Ortho-Oncology, Survivorship, Cancer Predisposition, Bone Marrow Failure, and others. Kami has helped identify, counsel, connect, and coordinate surveillance for children with Li-Fraumeni syndrome in these, as well as in General Genetics, clinics. Kami has co-authored multiple publications on pediatric cancer genetic counseling, and she was the founding chair of the Pediatric Subcommittee of the NSGC’s Cancer Special Interest Group in 2014.
Chieko Tamura, M.S.
Chieko Tamura studied genetic counseling as a Fulbright scholar at the joint graduate program of the National Human Genome Research Institute and Johns Hopkins University School of Public health, graduating in 2003. By 2005, she was certified as a genetic counselor by the American Board of Genetic Counseling as well as the Japanese Board of Genetic Counseling. She is a board member of the Japanese Association of Certified Genetic Counselors, and worked as an intern genetic counselor in the USA. She has worked in a variety of settings to include prenatal, pediatrics, adult genetics, cancer genetics, neurogenetics, and infertility, etc. at many different medical institutions, including the Japan’s National Center for Child Health and Development, several university hospitals and major fertility clinics. She has also worked as an associate professor at the genetic counseling training graduate program at Ochanomizu University of Tokyo, and served as co-director of the program. Chieko has also worked in psychosocial genetic counseling, grief counseling, disability studies, research methodology, and bioethics.
Sarah Scollon, M.S., C.G.C.
Sarah Scollon is a genetic counselor with the Cancer Genetics and Genomics Program at Texas Children’s Hospital. Her clinical focus is on genetic counseling for patients and families at risk for or diagnosed with pediatric cancer predisposition syndromes including Li-Fraumeni syndrome. Ms. Scollon’s research interests include pediatric cancer predisposition syndromes and educating healthcare providers in recognizing at risk patients and families in order to provide education, advocacy, and increase the adoption of prevention and screening for future cancers. She also has conducted research involving the incorporation of genomic sequencing into the care of children with cancer. Her ongoing research will look into the incorporation of genetic counseling into personalized medicine.
Samantha Culver, M.S., C.G.C.
Samantha Culver is a board certified genetic counselor with the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute in Boston. She received her MS in Genetic Counseling from Boston University School of Medicine. She sees adult patients with personal and family histories of cancer, and has a special interest in breast cancer genetics and Li-Fraumeni syndrome. In addition to her clinics on the Boston campus, Samantha provides telemedicine services to Concord Hospital in New Hampshire and Eastern Maine Medical Center in Bangor, Maine.
Emily Quinn, M.S., C.G.C
Emily Quinn is a licensed board-certified genetic counselor with clinical expertise in pediatric cancer genetic syndromes. Born and raised in California, she received her bachelor’s degrees in biology and psychology at the University of California, Santa Cruz before moving to New York City to complete her master’s degree in genetic counseling at the Icahn School of Medicine at Mount Sinai. Given her particular interest in cancer genetics and a strong desire to work with children, Emily moved to Memphis, Tennessee in 2014 to join the newly-created Division of Cancer Predisposition at St. Jude Children’s Research Hospital. In her role at St. Jude, Emily worked with many families living with Li-Fraumeni syndrome and developed a deep appreciation for the profound impact that a diagnosis of LFS has on not only patients, but the entire family. In 2018, Emily left clinical care to help build the Master of Science in Human Genetics and Genetic Counseling program at the Keck Graduate Institute in Claremont, California. Emily’s primary academic passion is anchored in education and increasing the accessibility of genetics knowledge to patients and established healthcare providers and new trainees. Her research interests include development of age-appropriate tools and strategies for children and families to talk about genetics and cancer risk.
Shannon Stasi, M.S., L.C.G.C.
Shannon Stasi is a board certified and licensed genetic counselor in the Department of Laboratories and Brain Tumor Clinic at Seattle Children’s Hospital (SCH). She received her MS in Genetic Counseling from Boston University School of Medicine. She sees pediatric patients with personal and family histories of cancer, and has a special interest in brain cancer genetics and Li-Fraumeni syndrome. She also supports the SCH genetics sub-specialty labs and is part of the consulting team that reviews and approves requests for “send-out” genetic tests. She is involved in developing best practice recommendations related to genetic testing, including appropriate pre-test evaluations, sequential testing strategies, pre-test and post-test counseling, and insurance pre-authorization for genetic tests. She is a member of the leadership team of PLUGS® (Patient-Centered Laboratory Utilization Guidance Services), a national collaboration of institutions working on test stewardship strategies to improve the value of testing for families and providers.
Lamia Fahad Alsubaie, M.S., G.C.
Lamia Fahad Alsubaie is a genetic counselor and blogger specializing in genetic medicine. She graduated from Joan H. Marks Human Genetic Program – Sarah Lawrence College ’15, and received bioethics training as genetic counseling candidate at Columbia Center for Bioethics, as well as pediatrics genetics and cytogenetics training at Columbia Medical Center. She is senior genetic counselor at King Abdulaziz Medical City – National Guard Health Affairs, and she launched the first specialized cancer genetic counseling clinic in Saudi Arabia. Lamia is a part-time research genetic counselor at King Fahad Medical City, and a part-time instructor at the genetic counseling Master’s program at Al-Faisal University. Lamia contributed to a clinical team leading the 1000 Saudi familial cancer patients’ initiative to establish the first cancer genetic screening and surveillance program in the Kingdom of Saudi Arabia. Additionally, she is involved in research with the King Abdullah University of Science and Technology, and a multi-language patients resources project with the international special interest group at National Society of Genetic Counselors. Her clinical interest is mainly in onco-genetic counseling, general genetic counseling, and lab genetic counseling. She devotes her efforts in promoting the profession of genetic counseling in Saudi Arabia, and in creating professional content resources for the public, patient families, and health-care providers interested in genetic/genomic science from all over the Arab world. Lamia is also serving as the chapter chair for the LFS Association – Saudi Arabia Chapter.
Megan Frone, M.S., C.G.C.
Megan Frone is a board certified genetic counselor with the Clinical Genetics Branch (CGB) of the National Cancer Institute (NCI) in the Division of Cancer Epidemiology and Genetics (DCEG), where she serves as the lead the lead genetic counselor for the NCI Li-Fraumeni Syndrome Study. Megan received her Bachelor of Science in Biology (Concentration in Cell & Molecular Biology) from SUNY Binghamton University in 2008 and her Masters in Genetic Counseling from Virginia Commonwealth University in 2010 where she also graduated the Virginia Leadership Education in Neurodevelopmental Disabilities (Va-LEND) program. Prior to joining the CGB, Megan worked as an Adult and Pediatric Cancer Genetics Counselor at UT Southwestern Medical Center in Dallas, TX, and in the Inborn Errors of Metabolism; Down Syndrome Specialty; and General Pediatrics Genetics Clinics at Childrens Health, Dallas. Outside of the clinic, her primary role is the development and implementation of gene variant annotation and classification for various DCEG clinical and research initiatives. Megan is also the lead genetic counselor for evaluation of whole exome data on the Childhood Cancer Survivor Study, a study of several thousand long-term childhood cancer survivors to identify common and rare genetic variants that influence risk of second cancers as well as variants that modify the effects of radiotherapy and chemotherapy and subsequent cancer risk. Megan’s primary interest and focus for the last several years has centered on pediatric cancers, secondary cancer risks in childhood cancer survivors, and bioinformatics and variant curation. Megan served as the Co-Chair of the Pediatric Subcommittee of the Cancer Special Interest Group of the National Society of Genetic Counselors from 2014-2016 and is currently the Co-Chair of the Cancer Special Interest Group Executive Board.
Carly Grant, M.S., L.C.G.C.
Carly Grant received her bachelor’s degree at Haverford College and her Master’s degree in genetic counseling at Brandeis University. She currently works at the Massachusetts General Hospital Center for Cancer Risk Assessment. She previously worked at Dana-Farber Cancer Institute where she saw adult and pediatric patients and worked with several LFS families who impacted her profoundly. Ms. Grant loves the educational and emotional aspect of her work and is particularly interested in the psychosocial needs of families with LFS. Also a runner, Ms. Grant recently raised money for the LFSA while training for her 6th marathon.
Alexandra Suttman, M.S., C.G.C.
Alexandra “Ali” Suttman is a board certified genetic counselor and instructor at Children’s Hospital Colorado in the section of Hematology, Oncology, and Bone Marrow Transplantation. She completed her master’s degree in genetic counseling at the Ohio State University and her bachelor’s degree in ecology and evolutionary biology at the University of Colorado at Boulder. Ali specializes in pediatric oncology, immunohematology, polyposis, and bone marrow failure conditions, with special interest in Li-Fraumeni syndrome. Ali sees patients as a member of a comprehensive care team for patients and families with hereditary disorders, providing pre-test counseling, aid in results interpretation, psychosocial support, and medical management support and advocacy. Ali’s research interests include further characterizing the clinical spectrum of “orphan” diseases and the psychosocial impact of genetic testing, genetic counseling, and hereditary disorders.
Bailey Gallinger, M.Sc., C.G.C.
Bailey Gallinger has been a genetic counselor in the Division of Clinical and Metabolic Genetics at Toronto’s Hospital for Sick Children since 2014. Bailey received a Master of Science in Genetic Counseling from Brandeis University in 2012, following which she worked in prenatal and cancer genetic counseling in Florida. In 2012, she received her certification in genetic counseling from the American Board of Genetic Counseling (ABGC). She is actively involved in the University of Toronto M.Sc. Program in Genetic Counseling as a lecturer, and is a clinical supervisor to students in the M.Sc. Program in Genetic Counseling and to genetic residents and fellows. As a genetic counselor in the Cancer Genetics Program, Bailey assesses the cancer risk of patients and families, helping them navigate the complexities of hereditary cancer predisposition syndromes. She assists with recommendations and referrals to other specialties, contributing to early cancer detection and therefore more favorable outcomes for individuals at high-risk for cancer. Bailey’s main research area of focus is how new genetic testing technologies can impact pediatric cancer care. Bailey is a co-investigator on the SickKids Cancer Sequencing (KiCS) study and plays and integral role on multiple aspects of this initiative.
Jaclyn Schienda, Sc.M., L.G.C.
Jaclyn received her Sc.M. in Genetic Counseling from Johns Hopkins University in a joint training program with the National Institutes of Health. She joined Dana-Farber in 2012 after working in the pediatric and adult genetics clinic at Tufts Medical Center. She has worked in many different areas of genetic counseling here and is currently the lead genetic counselor in the Pediatric Cancer Genetic Risk Program in the Jimmy Fund Clinic. Jaclyn is interested in communication of genetic risk and health information to children and families, as well as genetic causes of cancer in children.
Jacquelyn Powers, M.S., L.C.G.C.
Jacquelyn Powers is a licensed board-certified genetic counselor with a Master’s degree in genetic counseling from the University of North Carolina- Greensboro, and a bachelor’s of science from the State University of New York- Geneseo. She has worked as a lead genetic counselor at the Abramson Cancer Center at the University of Pennsylvania as well as the Basser Center for BRCA since 2009. She has also worked as project manager for the international prostate screening study in BRCA1/2 carriers (IMPACT), serves on the public policy committee for the National Society of Genetic Counselors, and is course coordinator for Arcadia University’s Master’s level, “Introduction to Cancer Genetics.” Jacquelyn’s research interests include discordant TP53 variant classifications and their impacts on patient care, and germline implications of somatic tumor testing.
Alison Schwartz, M.S., L.G.C.
Ali Schwartz is a licensed board certified genetic counselor with the Center for Cancer Genetics and Prevention at Dana-Farber Cancer Institute in Boston. She received her MS in Genetic Counseling from Boston University School of Medicine. Ali provides genetic counseling services to adult patients with personal and family histories of cancer and has a special interest in Li-Fraumeni syndrome. She also provides telemedicine services to St. Elizabeth’s Medical Center in Boston and South Shore Hospital in South Weymouth, Massachusetts. Ali has particular interests in improving access to genetic counseling services among diverse groups and improving genetic health education among the public.
Joyce Turner, M.Sc., C.G.C.
Joyce Turner earned her undergraduate degree from Syracuse University and her Masters of Science in Medical Genetics from the University of Cincinnati. In 2002 she received her ABGC board certification. Joyce worked at the National Human Genome Research Institute at the National Institutes of Health as a co-investigator, genetic counselor, and study coordinator before taking a position at the Children’s National Medical Center (CNMC), in the Department of Genetics, where she is now the Director of the Cancer Genetic Counseling Program, a program which she helped established and now heads. Joyce also works in the Department of Oncology at CNMC where she is assisting with a study focusing on precision medicine for pediatric oncology patients. She has a special interest in cancer screening and prevention, and provides long-term surveillance for children with Li-Fraumeni syndrome. Joyce is an Assistant Professor of Pediatrics at the George Washington University Medical Center and serves as a supervisor for genetic counseling graduate students.
Jennifer Kennedy, M.Sc., C.G.C.
Jennifer Kennedy graduated with a Bachelor of Science in Psychology from the University of Victoria, Canada, and went on to receive her Master’s degree from the Joan H. Marks Human Genetics Program at Sarah Lawrence College in 2013. She is a board-certified genetic counselor who has specialized in pediatrics, previously at the International Fanconi Anemia Registry and currently at Memorial Sloan Kettering Cancer Center (MSKCC). Jennifer works within a multidisciplinary team to evaluate families who may have a genetic predisposition to solid tumors, hematologic malignancies, or immunodeficiency. She is passionate about education and is currently involved in the establishment of a local support group at MSKCC that will provide access to psychosocial and networking support for individuals and families affected by LFS.
Eliza Courtney, M.G.C., C.G.C.
Eliza Courtney is an internationally experienced certified genetic counselor, currently working in the field of pediatric cancer predisposition and precision medicine based in Sydney, Australia. Previously she worked across a number of tertiary hospitals in Sydney before moving to Singapore, where she was based at the National Cancer Centre Singapore for several years. Here she led and contributed to clinical and health services research with the goal of improving access to genomic technologies and subsequent risk management for diverse populations. Upon returning to Australia, she has primarily worked on the ZERO Childhood Cancer national precision medicine projects as a Research Genetic Counselor and holds appointments at the Children’s Cancer Institute and Sydney Children’s Hospital, Randwick. She has a keen interest in further elucidating the heritable contribution to childhood tumorigenesis using integrated germline-tumor analyses and the clinical utility of such information and has started a PhD on this topic. Eliza is part of the Australasian Society of Genetic Counsellors Executive and contributes to the development of national cancer genetics guidelines as part of the eviQ Pediatric and Adult Cancer Genetics Reference Committees. She has had the immense privilege of providing genetic counseling for a number of families with Li-Fraumeni syndrome and as a result, is extremely passionate about improving outcomes for people with this condition.
Meera Warby, C.G.C.
Meera Warby is a certified genetic counselor At the Prince of Wales Hospital Hereditary Cancer Centre, Sydney Australia. She has received her Bachelor of Biomedical Science if Forensic Biology at the University of Technology Sydney and completed her Master of Genetic Counseling from The University of Sydney in 2012. She has six years of cancer genetic counseling experience with a main clinical focus on pediatric cancer genetics. In addition to her clinical experience, Meera is also working with a precision medicine trial for high risk pediatric oncology patients. Meera developed a special interest in Li-Fraumeni syndrome as a result of working closely with a number of Li-Fraumeni families. Meera has a keen interest in how risk information is conveyed to children and parents and how their needs may differ.
Jasmine obtained her Bachelor of Biotechnology and Biomedical Science from RMIT University and Master of Science and Graduate Diploma in Genetic Counselling from The University of Melbourne. Her primary clinical role is to provide risk assessment and genetic counselling to patients seen in the familial cancer clinic at Austin Hospital, Melbourne, Australia. She also coordinates the High Risk Management clinic for women at increased risk of breast and/or ovarian cancer. Prior to this role, Jasmine worked with the LFS research study group under the guidance of Dr Louise C. Strong at MD Anderson Cancer Center in Houston, Texas. She was involved in the establishment and operation of the Li-Fraumeni Syndrome Education And Early Detection (LEAD) clinic for both adults and children at MD Anderson Cancer Center. In addition, she contributed to the development of LFS screening algorithms for adults and children at MD Anderson and contributed to research studies related to LFS. Jasmine continues to support families affected by LFS through her clinical work in Australia. In addition, she remains dedicated to developing more research in this area by serving as an advisory board member for students pursuing research projects related to Li-Fraumeni Syndrome.
Natalie Waligorski, MS, MPH, CGC
Natalie Waligorski is a board certified and licensed genetic counselor in the Cancer and Blood Disorders Center at Seattle Children’s Hospital. She received her MS in Genetic Counseling and MPH in Health Behavior and Health Education from the University of Michigan. She sees pediatric patients with a personal and family history of cancer in the solid tumor clinic. She also supports the Cancer Predisposition Clinic which serves as a medical home for pediatric patients identified to have a hereditary cancer predisposition syndrome, including Li-Fraumeni syndrome. She is particularly interested in understanding multilevel factors that impact health outcomes for patients with hereditary cancer predisposition syndromes and familial communication of genetic test results.
Jessica Hatton, MS, CGC
Jessica Hatton is a board certified genetic counselor with a bachelor’s degree in chemistry from Wheaton College and a master’s degree in genetic counseling from Virginia Commonwealth University. She currently works with the Clinical Genetics Branch (CGB) of the National Cancer Institute (NCI) as a federal contractor and provides genetic counseling and testing to individuals enrolled in the NCI Li-Fraumeni syndrome study. She is also a biocurator for the ClinGen TP53 Variant Curation Expert Panel which works to more objectively sort and classify TP53 variants according to whether or not they are believed to cause Li-Fraumeni syndrome. Jessica is interested in better understanding the spectrum of Li-Fraumeni syndrome and other hereditary cancer syndromes across individuals and families.
Jennifer Nuk, MSc, CGC, CCGC
Jennifer Nuk is a genetic counselor and the Clinical Coordinator with the provincial BC Cancer Hereditary Cancer Program in British Columbia, Canada. She received her Masters of Science in Genetic Counseling from the University of British Columbia in 2006 and has been working with families living with hereditary cancer risk ever since. Jennifer is a Clinical Assistant Professor with the University of British Columbia’s Department of Medical Genetics where she provides lectures, clinical supervision and research project leadership to genetic counseling students. She has a keen interest in evolving the practice of genetic counseling with alternate service delivery models, increasing access to inclusive genetic services for under-served and diverse populations, enhancing public and health care provider education, working with multi-disciplinary teams to ensure availability of appropriate hereditary cancer surveillance and developing systems of support following the receipt of genetic test results for patients and their families.
Christy Smith, ScM, CGC
Christy Smith received her Masters of Science degree from the Johns Hopkins School of Public Health/National Human Genome Research Institute genetic counseling program in 2011. She is a board-certified senior genetic counselor who has worked in the Johns Hopkins University Department of Genetic Medicine in Baltimore, MD since 2016. She has worked in a variety of clinical settings including pediatric/adult genetics, neurogenetics, ophthalmology genetics, and hereditary disorders of connective tissue; but currently has a particular interest and focus on pediatric cancer genetics. She has 10 years of experience in cancer genetic counseling, and has been the leading and founding genetic counselor for the Pediatric Cancer Predisposition Clinic at Johns Hopkins. She currently works with a multidisciplinary team of providers within the Johns Hopkins Kimmel Cancer Center’s Division of Pediatric Oncology in seeing children and families with pediatric cancer predisposition syndromes, including Li-Fraumeni syndrome. Her interests include educating and mentoring other healthcare providers, residents, fellows, medical students, and genetic counseling students about these conditions as well as recognizing and managing at risk patients and families. She has also lectured and published about cancer genetic counseling. She is passionate about issues surrounding diversity, equity, inclusion, and justice both in her work with patients and colleagues. She is an active member of the National Society of Genetic Counselors, including the Cancer Special Interest Group Pediatric Subcommittee, and the Maryland DC Society of Genetic Counselors, where she is one of the founding members of the Diversity, Equity, Inclusion, and Justice (DEIJ) Subcommittee.